Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I saw you post this somewhere else and it turned my eye, I like this play also, i read a news report a long time ago about the enormous value of up and coming casinos/race tracks etc especially dependant on location. Can be a big help to jobs and people in a desolate environment. Im in virginia and near by is Charlestown WVA, they have slots/race tracks and have been getting bigger and bigger. They added highways, thoussands of houses, Home DEpots, etc. Many think Casinos can bring down a environment but it can also be a kick start to a flourishing economy. In any case, the potential revenue to be brought in is huge. This play might take a while but getting in down here will definately make you happy. GLTA
Oh i was just wondering what you thought, Thanks for input
. I have been in since .0013 for weeks now and was about to dump this when it fell to .0004, I was sick of their IR, BIg APPLE consulting, those guys suck and have no clue whats going on. Glad i held to see spread tighten up. With some more Momo this could easily see .004 +.
U think SRSR has anything left in the tank?? is this a slight pullback for a bigger run or do you think its over?
SRSR getting some action, SHWK bid building .016x .017 ready to go
SHWK .016x.017 ready to go as well!!
IM in still and very happy at what i see this morning, ED is in also and i hope he knows whats happening, by the time he gets back this might be back to .0004 (i hope not). He sent them a pretty good straight forward email as well. Their IR sucks but maybe they got something up their sleeves. Anyways Thanks for headsup on this one HippyChix
SRSR come on keep going. this thing trades weird as anything. was at .008 x .012 before then crashed to .004 few days ago. Now its getting back up there. with volume like this maybe we can see a nice run soon.
SHWK ask UT .017 now, with continued volume who knows how high this will go, just getting started IMO
SHWK Ask UT .017
take care Ed, stop by when u can, hopefully this boring time will end soon.
AWYI .0017 x .0019 ASK UT
just got back in from good old toronto, I love Molson Canadian up there, so much better. need to sleeep..... Glad to see SHWK heating up, AWYI steadily building higher base and UPHN still ready to go.
Dont know what to do with my huge ANWM pile. MLKNA acquired controlling interest in them and it did nothing to the pps. Weird considering only has 24 mil float i think.
SRSR is veerry tough, it actually was at .0012 before dropping yesterday but spread is so large nobody could sell at that level and it looks like someone slammed the bid thus causing us to be where we are and drop even lower. I have been in since .0011 but really wish I had not. There are many red flags about this company and its former name etc over on HSM. The email correspondance was mind blowing, the person emailed me a old PR and hd no clue about current one out and said things like "peace" and just sounded so off. I have no choice but to hold this as a lotto play and hope some day with momo i will be able to get rid of my shares. Just a heads up, I enjoy mostly all the plays most of us are in over here but i will be selling this the minute i can, its just off and seems like a POS. WHo cares though, we have made money off of these types before and i hope we can later if it sees any kind of run. GLTA
AWYI bid building. WAll at .025 will slowly deteriorate.
the movment is because 10q came out
AWYI .. As of May 17, 2007, the Company had outstanding 66,137,873 shares of its common stock, $0.001 par value share.
way to cheap downhere
10q out, looks good, ready to go, need to break .02 and stay there
radar AWYI, way undervalued, ready to go 10q out
AWYI MOVING .002 ahead, 10q out, way undervalued
AWYI moving , 10q out, way undervalued
AGEN HUGE NEWS OUT TODAY!
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer
Monday May 21, 11:00 am ET
Overall Survival Improvement Also Observed in Intermediate-Risk Kidney Cancer Patients Who Received Oncophage
Antigenics Presents Updated Phase 3 Results at the American Urological Association Annual Meeting
Conference Call To Be Held Today at 1:30 p.m. ET
ANAHEIM, Calif.--(BUSINESS WIRE)--Antigenics Inc. (NASDAQ: AGEN - News) today announced additional follow-up data on the company's Phase 3 investigational therapeutic cancer vaccine Oncophage® (vitespen). The end-of-study results, which reflect an additional 17 months' data collection, showed that in a substantial subset of patients (n = 362) at intermediate risk for disease recurrence, Oncophage demonstrated a clinically significant improvement in recurrence-free survival (RFS) of approximately 45 percent (P less than 0.01; hazard ratio (HR) = 0.55). In addition, updated analysis in this group of patients revealed a new potential benefit associated with Oncophage treatment: for intermediate-risk patients there was a trend towards improved overall survival, the study's secondary endpoint. Furthermore, the positive overall survival trend observed to date correlates with the RFS improvement demonstrated in previous analyses. This is the largest, randomized Phase 3 kidney cancer trial ever completed in the adjuvant treatment setting.
Source: Antigenics Inc.
· Intermediate-risk RCC patients diagram (Graphic: Business Wire). View Multimedia Gallery
Christopher G. Wood, MD, associate professor of urology at M. D. Anderson Cancer Center in Houston, presented the Phase 3 end-of-study results at the annual meeting of the American Urological Association (AUA; abstract #633).
"These results continue to underscore the significant potential benefit of Oncophage in a well-defined, clinically and biologically relevant subset of patients who are the most appropriate candidates for cancer vaccines," said Dr. Wood. "In addition, there are currently no approved therapies for these patients, which represent a growing and significant population due to increased use of early detection techniques."
"We are particularly encouraged to see that the clinically significant trend observed from our earlier analysis has been strengthened by the updated data from an additional 17-month follow-up of patients," said Garo H. Armen, PhD, chairman and CEO of Antigenics. "Although there are challenges associated with interpretation of subset analyses, the improvement demonstrated in this group of patients supports the opinion of key experts that patients with better prognostic factors are the most appropriate population to benefit from therapeutic cancer vaccines. Combined with decades of preclinical and clinical cancer vaccine data, we believe our results provide a higher level of reliability than that generally associated with outcomes from typical subset analyses."
Study Findings
Results from the investigator-reported data, which represented all data collected through the end of study (March 31, 2007), showed that:
Patients receiving Oncophage in the intermediate-risk population (stages I/II high-grade, III T1/2/3a low-grade) who were without disease at baseline (n = 362) demonstrated a clinically significant improvement in recurrence-free survival of approximately 45 percent (P less than 0.01; HR = 0.55). This patient population is defined by the Eastern Cooperative Oncology Group (ECOG) as at intermediate risk for disease recurrence*. Although the median survival has not yet been reached, results from the 25th percentile indicate that recurrence-free survival was extended by approximately 1.8 years in the Oncophage arm.
Analysis of overall survival showed improvement associated with Oncophage in the intermediate-risk population. As of data cut-off on January 2, 2006, one additional patient had died in the Oncophage arm versus 13 patients in the observation arm. This now brings the total reported deaths to 15 patients (8.2 percent) in the Oncophage arm compared with 25 deaths (14.0 percent) in the observation arm. The overall survival data are still immature due to the small number of deaths that have occurred to date; patients will continue to be monitored for survival through a global patient registry.
Among all eligible patients (intermediate- and high-risk patients without baseline disease; n = 604), Oncophage was associated with an 11.4 percent improvement in recurrence-free survival, which was not statistically significant (HR = 0.89).
There was also a promising trend for overall survival associated with Oncophage in the eligible patient population (n = 604). As of data cut-off on January 2, 2006, 24 additional deaths have been reported, with six in the Oncophage arm and 18 in the observation arm, bringing the total to 37 (12.3 percent) and 40 (13.2 percent) deaths, respectively.
Adverse events reported during the trial were generally mild and expected. The more frequently reported adverse events were mainly constitutional in nature or related to the actual injection.
The company is working with study investigators to publish the final findings in a peer-reviewed medical journal.
Antigenics To Continue To Follow Patients for Recurrence-Free Survival and Overall Survival Through a Global Patient Registry
haha i figured that also, but it is also one hell of a stock. just track it after May 22nd post split. haha its funny, they number one fertilizer company and call themselves POT, maybe thats whats got them into Fertilizer. I wish i knew how to make money with some DIRT haha.
Hey i see u also the MOD of the POT board, ive been in that for a little now but never checked it out here, man 3 for 1 split coming and i think it will go from around 70 back to upper 100's in 6-9 months, I think one of best plays on big boards. Earnings, gross margin, and cash flow getting bigger and better it seems every quarter.
UPHN break of .11 next week would be great. this one is steadily uptrending. no limits if it starts running.
UPHN break of .11 would be nice next week and just the start IMO, there has to be a reason this has held nicely and is uptrending since hitting .01/.02 about a month ago.
A lot of people like Stocklobster, Chevy53 here on I-hub think that convertible debentures are the first sign/red flag on a shell play to stay away from. What is your take on this?
ALso here is a excellent list of 240 shells made by Chevy53 that has status, owbership etc
http://www.investorshub.com/boards/read_msg.asp?message_id=19737681
reverse mergers board post #1064
Hi, you said ADBN does not have stand by equity agreements with cornell but now im confused after reading this..
On April 2, 2007, the Company entered into a Securities Purchase Agreement with Cornell Capital Partners, LP (the “Investor”). Pursuant to the Agreement, the Company issued to the Investor a total of Sixty Five Thousand Seven Hundred Dollars ($65,700) of secured convertible debentures which shall be convertible into shares of the Company’s common stock, par value $0.001 which was funded on the Closing Date for a total purchase price of up to Sixty Five Thousand Seven Hundred Dollars ($65,700). The conversion price of the convertible debentures is the lesser of (a) $0.0002 or (b) seventy five percent (75%) of the lowest Closing Bid Price during the ten (10) Trading Days immediately preceding the Conversion Date. In addition, Company issued a warrant to the Investor to purchase up to 328,500,000 shares of the Company’s common stock at $0.0002 per share. The warrant is exercisable for five years from the date of issuance
Does that mean Cornell can buy stock at .0002 anytime in next five years or that they can not excercise the shares they bought at .0002 presently until 5 years has passed? Maybe its not stand by equity agreement but is this funding anything like the 1 million tlbt, etc received from cornell or is it in the same method? thanks any input would be greatly appreciated
MLKNA probably going to get all restricted stock of ANWM most likely than i dont know what else. Big news though, MLKNA went from .20 cents to over 2.00 earlier this year. ANWM has always been fully reporting so uplist is very likely. ANWM 24 mil float. DAMN i never thought the deal would go through but it did. ANWM also positive 1st quarter revenues as well. ANWM way undervalued here at .045 but .055 break is the key.
MLKNA acquires 67% of ANWM- controlling interest. ANWM has positive 1st quarter revenues and now getting acquired by MLKNA who broke 52 week highs earlier. ANWM 24 mil float i believe
ISLANDIA, NY--(MARKET WIRE)--May 15, 2007 -- MedLink International, Inc. (OTC BB:MLKNA.OB - News) announced today that it has acquired a controlling interest of Anywhere MD, Inc. (Other OTC:ANWM.PK - News), a leading provider of mobile EMR solutions to healthcare facilities in the chiropractic market.
ADVERTISEMENT
Under the terms of the Definitive Agreement signed May 14, 2007, MedLink acquired 67% of the total outstanding stock of Anywhere MD, Inc. Anywhere MD will continue to operate as a separate entity as a subsidiary of MedLink International, Inc., and Steven J. Hixson, founder of Anywhere MD, will stay on as Anywhere MD's Chief Executive Officer.
With the acquisition of Anywhere MD, MedLink will add an additional 4,400 doctors to its network. This acquisition is part of MedLink's roadmap of becoming the largest physician network in the U.S.
Ray Vuono, CEO, MedLink International, Inc., stated, "Anywhere MD, a proven industry leader, is an ideal acquisition for MedLink. Our strategic vision remains unchanged and we believe this transaction in addition to adding significant revenue creates greater growth opportunities for MedLink and our shareholders and allows for us to accelerate our existing expansion plans. This is an extremely complementary acquisition that accomplishes a number of MedLink's key objectives. MedLink is executing on its commitment to establish itself as the largest physician network in the U.S. This transaction will allow for both companies to strengthen and expand their core businesses and competencies, while creating significant opportunities for expansion and growth."
Anywhere MD will work with MedLink to integrate many of the tools of the MedLink EHR into its Auto-Pilot and Auto-DOC EMR solution and offer the upgraded solution to its existing client base of 4,400 physicians.
Steven J. Hixson, CEO, Anywhere MD, Inc., stated, "Anywhere MD applications have been a leading solution for the chiropractic market for years and by integrating with MedLink technologies we believe this will allow for tremendous growth within the next 12 months. Together, our companies will be able to compete more effectively. The integration of the MedLink EHR and the technological enhancements will allow for us to increase our sales while offering a more complete product suite to our customers."
James Decker, Exec VP of Sales, MedLink International, commented, "MedLink stands to gain from the wealth of knowledge Anywhere MD has gained in its nearly 15 years of experience in the HIT market as well as retain their 4,400 physicians as clients and offer additional MedLink products and services such as the MedLink TV and MedLink Billing solutions."
About Anywhere MD, Inc.
Anywhere MD, Inc. (Other OTC:ANWM.PK - News) provides state-of-the-art HealthCare Technologies that are shaping a new generation of patient care. Anywhere MD's expertise in clinical documentation for physicians offers a broad range of technology products to improve productivity for healthcare providers and enable them to diagnose, treat and manage patient information at the highest level.
Anywhere MD, Inc. develops, markets, sells and supports proprietary software applications for mobile handheld devices. These mobile applications provide the physician with the most recent and accurate healthcare information at the "Point Of Care." This technology eliminates a confusing and tedious 'paper trail' that can lead to inaccurate and inadequate patient charting, resulting in malpractice suits and poor patient care.
ANWM is headquartered on the central coast of California and is committed to serving thousands of healthcare professionals across the USA, Canada, Europe, Asia and Australia. Company web site is www.anywheremd.com
About MedLink International, Inc.
MedLink International is a publicly held NASDAQ Bulletin Board and Frankfurt Stock Exchange company (OTC BB:MLKNA.OB - News) (Frankfurt:WM6B.F - News), which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices.
The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing.
The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. Please visit www.medlinkus.com for more information.
Contact:
Contact:
Jameson Rose
MedLink International
631-342-8800 Ext 8804
ir@medlinkus.com
MLKNA acquires 67% of ANWM, ANWM at .045 now
ISLANDIA, NY--(MARKET WIRE)--May 15, 2007 -- MedLink International, Inc. (OTC BB:MLKNA.OB - News) announced today that it has acquired a controlling interest of Anywhere MD, Inc. (Other OTC:ANWM.PK - News), a leading provider of mobile EMR solutions to healthcare facilities in the chiropractic market.
ADVERTISEMENT
Under the terms of the Definitive Agreement signed May 14, 2007, MedLink acquired 67% of the total outstanding stock of Anywhere MD, Inc. Anywhere MD will continue to operate as a separate entity as a subsidiary of MedLink International, Inc., and Steven J. Hixson, founder of Anywhere MD, will stay on as Anywhere MD's Chief Executive Officer.
With the acquisition of Anywhere MD, MedLink will add an additional 4,400 doctors to its network. This acquisition is part of MedLink's roadmap of becoming the largest physician network in the U.S.
Ray Vuono, CEO, MedLink International, Inc., stated, "Anywhere MD, a proven industry leader, is an ideal acquisition for MedLink. Our strategic vision remains unchanged and we believe this transaction in addition to adding significant revenue creates greater growth opportunities for MedLink and our shareholders and allows for us to accelerate our existing expansion plans. This is an extremely complementary acquisition that accomplishes a number of MedLink's key objectives. MedLink is executing on its commitment to establish itself as the largest physician network in the U.S. This transaction will allow for both companies to strengthen and expand their core businesses and competencies, while creating significant opportunities for expansion and growth."
Anywhere MD will work with MedLink to integrate many of the tools of the MedLink EHR into its Auto-Pilot and Auto-DOC EMR solution and offer the upgraded solution to its existing client base of 4,400 physicians.
Steven J. Hixson, CEO, Anywhere MD, Inc., stated, "Anywhere MD applications have been a leading solution for the chiropractic market for years and by integrating with MedLink technologies we believe this will allow for tremendous growth within the next 12 months. Together, our companies will be able to compete more effectively. The integration of the MedLink EHR and the technological enhancements will allow for us to increase our sales while offering a more complete product suite to our customers."
James Decker, Exec VP of Sales, MedLink International, commented, "MedLink stands to gain from the wealth of knowledge Anywhere MD has gained in its nearly 15 years of experience in the HIT market as well as retain their 4,400 physicians as clients and offer additional MedLink products and services such as the MedLink TV and MedLink Billing solutions."
About Anywhere MD, Inc.
Anywhere MD, Inc. (Other OTC:ANWM.PK - News) provides state-of-the-art HealthCare Technologies that are shaping a new generation of patient care. Anywhere MD's expertise in clinical documentation for physicians offers a broad range of technology products to improve productivity for healthcare providers and enable them to diagnose, treat and manage patient information at the highest level.
Anywhere MD, Inc. develops, markets, sells and supports proprietary software applications for mobile handheld devices. These mobile applications provide the physician with the most recent and accurate healthcare information at the "Point Of Care." This technology eliminates a confusing and tedious 'paper trail' that can lead to inaccurate and inadequate patient charting, resulting in malpractice suits and poor patient care.
ANWM is headquartered on the central coast of California and is committed to serving thousands of healthcare professionals across the USA, Canada, Europe, Asia and Australia. Company web site is www.anywheremd.com
About MedLink International, Inc.
MedLink International is a publicly held NASDAQ Bulletin Board and Frankfurt Stock Exchange company (OTC BB:MLKNA.OB - News) (Frankfurt:WM6B.F - News), which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices.
The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing.
The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. Please visit www.medlinkus.com for more information.
Contact:
Contact:
Jameson Rose
MedLink International
631-342-8800 Ext 8804
ir@medlinkus.com
IS ANYBODY PAYING ATTENTION! DEAL is DONE MLKNA acquires controllign interest iN ANWM.
ISLANDIA, NY--(MARKET WIRE)--May 15, 2007 -- MedLink International, Inc. (OTC BB:MLKNA.OB - News) announced today that it has acquired a controlling interest of Anywhere MD, Inc. (Other OTC:ANWM.PK - News), a leading provider of mobile EMR solutions to healthcare facilities in the chiropractic market.
Under the terms of the Definitive Agreement signed May 14, 2007, MedLink acquired 67% of the total outstanding stock of Anywhere MD, Inc. Anywhere MD will continue to operate as a separate entity as a subsidiary of MedLink International, Inc., and Steven J. Hixson, founder of Anywhere MD, will stay on as Anywhere MD's Chief Executive Officer.
With the acquisition of Anywhere MD, MedLink will add an additional 4,400 doctors to its network. This acquisition is part of MedLink's roadmap of becoming the largest physician network in the U.S.
Ray Vuono, CEO, MedLink International, Inc., stated, "Anywhere MD, a proven industry leader, is an ideal acquisition for MedLink. Our strategic vision remains unchanged and we believe this transaction in addition to adding significant revenue creates greater growth opportunities for MedLink and our shareholders and allows for us to accelerate our existing expansion plans. This is an extremely complementary acquisition that accomplishes a number of MedLink's key objectives. MedLink is executing on its commitment to establish itself as the largest physician network in the U.S. This transaction will allow for both companies to strengthen and expand their core businesses and competencies, while creating significant opportunities for expansion and growth."
Anywhere MD will work with MedLink to integrate many of the tools of the MedLink EHR into its Auto-Pilot and Auto-DOC EMR solution and offer the upgraded solution to its existing client base of 4,400 physicians.
Steven J. Hixson, CEO, Anywhere MD, Inc., stated, "Anywhere MD applications have been a leading solution for the chiropractic market for years and by integrating with MedLink technologies we believe this will allow for tremendous growth within the next 12 months. Together, our companies will be able to compete more effectively. The integration of the MedLink EHR and the technological enhancements will allow for us to increase our sales while offering a more complete product suite to our customers."
James Decker, Exec VP of Sales, MedLink International, commented, "MedLink stands to gain from the wealth of knowledge Anywhere MD has gained in its nearly 15 years of experience in the HIT market as well as retain their 4,400 physicians as clients and offer additional MedLink products and services such as the MedLink TV and MedLink Billing solutions."
About Anywhere MD, Inc.
Anywhere MD, Inc. (Other OTC:ANWM.PK - News) provides state-of-the-art HealthCare Technologies that are shaping a new generation of patient care. Anywhere MD's expertise in clinical documentation for physicians offers a broad range of technology products to improve productivity for healthcare providers and enable them to diagnose, treat and manage patient information at the highest level.
Anywhere MD, Inc. develops, markets, sells and supports proprietary software applications for mobile handheld devices. These mobile applications provide the physician with the most recent and accurate healthcare information at the "Point Of Care." This technology eliminates a confusing and tedious 'paper trail' that can lead to inaccurate and inadequate patient charting, resulting in malpractice suits and poor patient care.
ANWM is headquartered on the central coast of California and is committed to serving thousands of healthcare professionals across the USA, Canada, Europe, Asia and Australia. Company web site is www.anywheremd.com
About MedLink International, Inc.
MedLink International is a publicly held NASDAQ Bulletin Board and Frankfurt Stock Exchange company (OTC BB:MLKNA.OB - News) (Frankfurt:WM6B.F - News), which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices.
The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing.
The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. Please visit www.medlinkus.com for more information.
Contact:
Contact:
Jameson Rose
MedLink International
631-342-8800 Ext 8804
ir@medlinkus.com
DRAGON DID U SEE THIS! MedLink Acquires Controlling Interest in Anywhere MD, Inc.
MLKNA is breaking 52 weeks highs and now got ANWM, i knew ANWM was sought after.
http://biz.yahoo.com/iw/070515/0252852.html
ISLANDIA, NY--(MARKET WIRE)--May 15, 2007 -- MedLink International, Inc. (OTC BB:MLKNA.OB - News) announced today that it has acquired a controlling interest of Anywhere MD, Inc. (Other OTC:ANWM.PK - News), a leading provider of mobile EMR solutions to healthcare facilities in the chiropractic market.
Under the terms of the Definitive Agreement signed May 14, 2007, MedLink acquired 67% of the total outstanding stock of Anywhere MD, Inc. Anywhere MD will continue to operate as a separate entity as a subsidiary of MedLink International, Inc., and Steven J. Hixson, founder of Anywhere MD, will stay on as Anywhere MD's Chief Executive Officer.
With the acquisition of Anywhere MD, MedLink will add an additional 4,400 doctors to its network. This acquisition is part of MedLink's roadmap of becoming the largest physician network in the U.S.
Ray Vuono, CEO, MedLink International, Inc., stated, "Anywhere MD, a proven industry leader, is an ideal acquisition for MedLink. Our strategic vision remains unchanged and we believe this transaction in addition to adding significant revenue creates greater growth opportunities for MedLink and our shareholders and allows for us to accelerate our existing expansion plans. This is an extremely complementary acquisition that accomplishes a number of MedLink's key objectives. MedLink is executing on its commitment to establish itself as the largest physician network in the U.S. This transaction will allow for both companies to strengthen and expand their core businesses and competencies, while creating significant opportunities for expansion and growth."
Anywhere MD will work with MedLink to integrate many of the tools of the MedLink EHR into its Auto-Pilot and Auto-DOC EMR solution and offer the upgraded solution to its existing client base of 4,400 physicians.
Steven J. Hixson, CEO, Anywhere MD, Inc., stated, "Anywhere MD applications have been a leading solution for the chiropractic market for years and by integrating with MedLink technologies we believe this will allow for tremendous growth within the next 12 months. Together, our companies will be able to compete more effectively. The integration of the MedLink EHR and the technological enhancements will allow for us to increase our sales while offering a more complete product suite to our customers."
James Decker, Exec VP of Sales, MedLink International, commented, "MedLink stands to gain from the wealth of knowledge Anywhere MD has gained in its nearly 15 years of experience in the HIT market as well as retain their 4,400 physicians as clients and offer additional MedLink products and services such as the MedLink TV and MedLink Billing solutions."
About Anywhere MD, Inc.
Anywhere MD, Inc. (Other OTC:ANWM.PK - News) provides state-of-the-art HealthCare Technologies that are shaping a new generation of patient care. Anywhere MD's expertise in clinical documentation for physicians offers a broad range of technology products to improve productivity for healthcare providers and enable them to diagnose, treat and manage patient information at the highest level.
Anywhere MD, Inc. develops, markets, sells and supports proprietary software applications for mobile handheld devices. These mobile applications provide the physician with the most recent and accurate healthcare information at the "Point Of Care." This technology eliminates a confusing and tedious 'paper trail' that can lead to inaccurate and inadequate patient charting, resulting in malpractice suits and poor patient care.
ANWM is headquartered on the central coast of California and is committed to serving thousands of healthcare professionals across the USA, Canada, Europe, Asia and Australia. Company web site is www.anywheremd.com
About MedLink International, Inc.
MedLink International is a publicly held NASDAQ Bulletin Board and Frankfurt Stock Exchange company (OTC BB:MLKNA.OB - News) (Frankfurt:WM6B.F - News), which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices.
The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing.
The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. Please visit www.medlinkus.com for more information.
Contact:
Contact:
Jameson Rose
MedLink International
631-342-8800 Ext 8804
ir@medlinkus.com
yeah all good questions that we need answers to. Please keep us posted with your answers after your call.
Who are you to tell everybody else when to sell or for what reason, u buy and sell on your own, dont try to make an attempt to drive this down, U shouldnt be in this at all or any penny play if you think a company is going to make your demands. Also u think there should be a turn around coming when u want it and bc it doesnt you and everybody else should sell. thats funny and also how u miss the big scope of things.
"If I dont see a turn around tomorrow in things I am getting out just like everyone else should"
SHWK getting some action, lots of buys at .01
UPHN verry thin, Ut's very easily, any volume and this will go easily into teens.
SHWK last 3 trades, this one just needs some news or volume and its gonna go also.
0.01 911 OTO 11:08:42
0.007 50000 OTO 11:07:08
0.009 100000 OTO 11:07:08
Dragon check out UPHN, .08 x .09, this UT's with ease man, i dont know when the real volume is coming but this has been making steady move since hitting .01/.02 just about month ago. when real volume shows up, high teens are coming.
In since .06 as well, this one is ready to go, UT'ing with ease, anyreal volume comes in and i think this runs into high teens. dont know who dumped some small shares last time this was at .09/.10 but ill take them if this hits .06 again. i wish i would have got some more but i had to call it in and got lazy.
uphn just ready for a massive move, with any volume this will fly into double digits. man i was going to add some at .06/.07 but i was stupid and didnt want to call it in.